Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis
- 28 September 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 56 (10), 3358-3365
- https://doi.org/10.1002/art.22941
Abstract
Objective To investigate the effect of osteoclastogenesis inhibitory factor/osteoprotegerin (OPG) on chondrocytes in the development of osteoarthritis (OA) in vivo. Methods To determine the role of endogenous OPG in the progression of OA, OA was surgically induced in OPG+/− mice and their wild‐type (WT) littermates. To determine the role of exogenous OPG, knee joints of C57BL/6J mice with surgically induced OA were injected intraarticularly with recombinant human OPG (rHuOPG) or vehicle 5 times a week. All mice were euthanized 4 weeks after OA induction; joints were harvested and evaluated immunohistochemically. Results Although OA changes were induced in both WT and OPG+/− mice, the degenerative changes in the articular cartilage were significantly enhanced in OPG+/− mice. In C57BL/6J mice with surgically induced OA, intraarticular OPG administration protected the articular cartilage from the progression of OA. The Mankin and cartilage destruction scores in OPG‐treated animals were ∼50% of those seen in the control group. Furthermore, OPG administration significantly protected articular cartilage thickness. Findings of the TUNEL assay indicated that rHuOPG prevented chondrocyte apoptosis in joints with surgically induced OA. Results of immunostaining indicated that OPG protein was detected in the synovium and in resident chondrocytes at higher levels in the OPG‐treated group than in the control group. Conclusion These data indicate that endogenous OPG had a protective effect against the cartilage destruction that occurs during OA progression. Furthermore, direct administration of rHuOPG to articular chondrocytes prevented cartilage destruction in an experimental murine model of OA via prevention of chondrocyte apoptosis.Keywords
This publication has 34 references indexed in Scilit:
- Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritisBone, 2005
- Genetics of Paget's disease of boneClinical Science, 2005
- The Role of Osteoprotegerin and Tumor Necrosis Factor-related Apoptosis-inducing Ligand in Human Microvascular Endothelial Cell SurvivalMolecular Biology of the Cell, 2004
- The role of subchondral bone remodeling in osteoarthritis: Reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection modelArthritis & Rheumatism, 2004
- TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritisArthritis & Rheumatism, 2004
- Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritisArthritis & Rheumatism, 2002
- Tumor necrosis factor α‐mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerinArthritis & Rheumatism, 2002
- Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in VivoThe American Journal of Pathology, 2000
- Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with OsteoporosisJournal of Bone and Mineral Research, 1999
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995